ZPL-3893787

· Ziarco Pharma Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZPL-3893787, covering 2021-05-13 to 2021-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis [Phase 2]